Spinal Muscular Atrophy (SMA) Biomarker Study (U01)

The summary for the Spinal Muscular Atrophy (SMA) Biomarker Study (U01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Spinal Muscular Atrophy (SMA) Biomarker Study (U01)
	CFDA Number:	93.853
	CFDA Description:	Extramural Research Programs in the Neurosciences and Neurological Disorders
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-NS-12-004
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Jun 09, 2011
	Creation Date:	Jun 09, 2011
	Original Closing Date for Applications:	Sep 01, 2011
	Current Closing Date for Applications:	Sep 01, 2011
	Archive Date:	Oct 02, 2011
	Expected Number of Awards:	1
	Estimated Total Program Funding:	1,750,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply, but will have to work with the U.S.-based NeuroNEXT infrastructure.
Grant Description: The purpose of this funding opportunity announcement (FOA), issued by NINDS, is to invite applications for a study of candidate biomarkers in Spinal Muscular Atrophy (SMA). The study will be done using the NeuroNEXT infrastructure (as established in response to RFA-NS-11-009, RFA-NS-11-010, RFA-NS-11-008) along with ad hoc clinical sites as appropriate. This is a milestone-driven cooperative agreement program involving participation of NIH staff in the development of the project plan and monitoring of research progress.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-ns-12-004.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • NINDS Research Education Programs for Residents and Fellows in Neurology, Neurosurgery, Neuropatholo...; • Exceptional, Unconventional Research Enabling Knowledge Acceleration (EUREKA) In the Epilepsies (R01...; • Limited Competition for Continuation of Induced Pluripotent Stem Cell (iPSC) Resources promoting Tra...; • Limited Competition for the Continuation of Rare Diseases Clinical Research Consortia in the Rare Di...; • NINDS PHASE III Investigator-Initiated Multi-Site Clinical Trials (U01); • NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44); • NINDS Institutional Center Core Grants to Support Neuroscience Research; • Career Development Award to Promote Diversity in Neuroscience Research; • Specialized Program of Translational Research in Acute Stroke; • NINDS Cooperative Program in Translational Research